Clinical Trials Browser

Phase 1 × lanreotide × Endocrine × Clear all

NCT05364944 2025-11-17

OXTEND-01

Phase 1 Terminated

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly